Wolfe bumps Eli Lilly target on oral obesity drug, cardiometabolic portfolio

Investing.com Gold reports: Wolfe bumps Eli Lilly target on oral obesity drug, cardiometabolic portfolio. This is a premium/paywalled source, so the brief is based on headline and available metadata only.